A recent study published in Indian Dermatology has found that tofacitinib, a drug commonly used for rheumatoid arthritis, has shown promising results in treating alopecia areata. The study revealed that 94.1% of the patients showed a complete or near-complete response to the medication. Additionally, 23.5% of the patients achieved complete hair growth within eight months of treatment.
